TNON

Several events have impacted TENON Medical, Inc.'s stock price in the past six months. On March 19, 2026, the company reported record revenue growth and improved gross margins for the fourth quarter and full-year 2025. On March 12, 2026, TENON Medical announced the closing of a private placement of senior convertible notes, raising $4.3 million. On February 25, 2026, the company received a letter from Nasdaq indicating that its common stock had not maintained the minimum bid price. On January 28, 2026, TENON Medical issued a shareholder letter highlighting preliminary revenue figures, the acquisition of SiVantage assets, and FDA clearance for an expanded indication for the Catamaran SI Joint Fusion System. The merger/acquisition with SiVantage occurred on August 1, 2025.